Pregled bibliografske jedinice broj: 864100
Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations
Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations // European Journal of Cancer Abstract Book / Eggermont, Alexander M.M. (ur.).
Amsterdam: Elsevier, 2017. str. 100-100 doi:10.1016/S0959-8049(17)30413-6 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 864100 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Combination of pomalidomide/dexamethasone in the
treatment of relapsed/refractory multiple
myeloma in patients with del(17p), t(4 ; 14) and
t(14 ; 16) chromosome aberrations
Autori
Katalinic, Darko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Cancer Abstract Book
/ Eggermont, Alexander M.M. - Amsterdam : Elsevier, 2017, 100-100
Skup
European Cancer Congress (ECCO 2017)
Mjesto i datum
Amsterdam, Nizozemska, 27.01.2017. - 30.01.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
pomalidomide, multiple myeloma
Sažetak
Combination of pomalidomide/dexamethasone in the treatment of relapsed/refractory multiple myeloma in patients with del(17p), t(4 ; 14) and t(14 ; 16) chromosome aberrations
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti, Dentalna medicina
POVEZANOST RADA
Projekti:
108-1080058-0047 - Molekularni biljezi u solidnim tumorima - prediktivni i prognostički značaj (Pleština, Stjepko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Osijek,
Fakultet za dentalnu medicinu i zdravstvo, Osijek
Profili:
Darko Katalinić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE